Ildong Holdings Co Ltd (KO:000230) — Market Cap & Net Worth
Market Cap & Net Worth: Ildong Holdings Co Ltd (000230)
Ildong Holdings Co Ltd (KO:000230) has a market capitalization of $76.14 Million (₩112.36 Billion) as of May 5, 2026. Listed on the KO stock exchange, this Korea-based company holds position #20238 globally and #1171 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ildong Holdings Co Ltd's stock price ₩9950.00 by its total outstanding shares 11292090 (11.29 Million). Analyse 000230 cash flow metrics to see how efficiently the company converts income to cash.
Ildong Holdings Co Ltd Market Cap History: 2015 to 2026
Ildong Holdings Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $195.75 Million to $76.14 Million (-8.69% CAGR).
Ildong Holdings Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ildong Holdings Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Ildong Holdings Co Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
Ildong Holdings Co Ltd's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $195.75 Million | $38.30 Billion | $20.98 Billion | 0.01x | 0.01x |
| 2016 | $169.45 Million | $40.77 Billion | $265.99 Billion | 0.00x | 0.00x |
| 2017 | $100.81 Million | $41.07 Billion | $651.62 Million | 0.00x | 0.15x |
| 2018 | $93.29 Million | $47.05 Billion | -$3.72 Billion | 0.00x | N/A |
| 2019 | $79.46 Million | $292.22 Billion | -$22.46 Billion | 0.00x | N/A |
| 2020 | $104.87 Million | $596.47 Billion | -$19.19 Billion | 0.00x | N/A |
| 2021 | $112.87 Million | $592.37 Billion | -$70.89 Billion | 0.00x | N/A |
| 2022 | $154.20 Million | $675.54 Billion | -$102.35 Billion | 0.00x | N/A |
| 2023 | $80.50 Million | $638.45 Billion | -$59.59 Billion | 0.00x | N/A |
| 2024 | $62.29 Million | $657.57 Billion | $63.04 Billion | 0.00x | 0.00x |
Competitor Companies of 000230 by Market Capitalization
Companies near Ildong Holdings Co Ltd in the global market cap rankings as of May 5, 2026.
Key companies related to Ildong Holdings Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
- Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #499 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #525 | Zoetis Inc | NYSE:ZTS | $50.31 Billion | $114.16 |
| #526 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.29 Billion | CN¥53.88 |
| #572 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $42.15 |
Ildong Holdings Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Ildong Holdings Co Ltd's market cap moved from $195.75 Million to $ 76.14 Million, with a yearly change of -8.69%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩76.14 Million | -25.13% |
| 2025 | ₩101.70 Million | +63.27% |
| 2024 | ₩62.29 Million | -22.62% |
| 2023 | ₩80.50 Million | -47.79% |
| 2022 | ₩154.20 Million | +36.62% |
| 2021 | ₩112.87 Million | +7.63% |
| 2020 | ₩104.87 Million | +31.97% |
| 2019 | ₩79.46 Million | -14.82% |
| 2018 | ₩93.29 Million | -7.46% |
| 2017 | ₩100.81 Million | -40.51% |
| 2016 | ₩169.45 Million | -13.43% |
| 2015 | ₩195.75 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Ildong Holdings Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $76.14 Million USD |
| MoneyControl | $76.14 Million USD |
| MarketWatch | $76.14 Million USD |
| marketcap.company | $76.14 Million USD |
| Reuters | $76.14 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Ildong Holdings Co Ltd
Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer's disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It is also involved in the… Read more